ABACAVIR/LAMIVUDINE 600/300 SUN abacavir 600 mg / lamivudine 300 mg tablets bottle Australia - English - Department of Health (Therapeutic Goods Administration)

abacavir/lamivudine 600/300 sun abacavir 600 mg / lamivudine 300 mg tablets bottle

sun pharma anz pty ltd - abacavir sulfate,lamivudine -

ABACAVIR/LAMIVUDINE 600/300 SUN abacavir 600 mg / lamivudine 300 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

abacavir/lamivudine 600/300 sun abacavir 600 mg / lamivudine 300 mg tablets blister pack

sun pharma anz pty ltd - abacavir sulfate,lamivudine -

Abacavir sulfate 60mg and Lamivudine 30mg Tablet Kenya - English - Pharmacy and Poisons Board

abacavir sulfate 60mg and lamivudine 30mg tablet

aurobindo pharma limited plot no. 11, survey 9, hitech city, hyderabad - abacavir sulfate & lamivudine - tablet - each tablet contains abacarvir sulfate 60mg and… - antivirals for systemic use:

TRELAVUE dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

trelavue dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle

viiv healthcare pty ltd - abacavir sulfate, quantity: 702 mg (equivalent: abacavir, qty 600 mg); lamivudine, quantity: 300 mg; dolutegravir, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; povidone; magnesium stearate; purified water; mannitol; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - trelavue is indicated for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age who are antiretroviral treatment-na?ve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents (dolutegravir, abacavir or lamivudine) in trelavue.

ZIAGEN TABLETS Israel - English - Ministry of Health

ziagen tablets

glaxo smith kline (israel) ltd - abacavir as sulfate - film coated tablets - abacavir as sulfate 300 mg - abacavir - abacavir - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infected .28/10/2018 בקשה לשינוי משטר מינון

ZIAGEN ORAL SOLUTION Israel - English - Ministry of Health

ziagen oral solution

glaxo smith kline (israel) ltd - abacavir as sulfate - solution (oral) - abacavir as sulfate 20 mg/ml - abacavir - abacavir - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infected .28/10/2018 בקשה לשינוי משטר מינון

ABACAVIR tablet United States - English - NLM (National Library of Medicine)

abacavir tablet

remedyrepack inc. - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir 300 mg

ABACAVIR tablet film coated United States - English - NLM (National Library of Medicine)

abacavir tablet film coated

avera mckennan hospital - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir 300 mg

ABACAVIR SULFATE tablet film coated United States - English - NLM (National Library of Medicine)

abacavir sulfate tablet film coated

avera mckennan hospital - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir 300 mg

ABACAVIR/LAMIVUDINE LAPL 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

abacavir/lamivudine lapl 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack

lupin australia pty limited - lamivudine, quantity: 300 mg; abacavir hydrochloride monohydrate, quantity: 714.162 mg (equivalent: abacavir, qty 600 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; ferric oxide; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - abacavir/lamivudine lapl is a combination of two nucleoside analogues (abacavir and lamivudine). abacavir/lamivudine lapl is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.